使用三维卷积神经网络预测癌症患者淋巴结最大标准化摄取值:一项概念验证研究
本研究收集了2017年连续初始分期PET/CT扫描,由两名盲法放射科医生从平扫CT部分选取淋巴结,记录其SUVmax,并训练一种新型3D CNN以肿瘤组织学类型和淋巴结图像为输入预测SUVmax。CNN在独立队列测试中,预测SUVmax与真实SUVmax相关(β估计值=0.83,p<0.0001),预测SUVmax与FDG亲和性相关(p<0.0001),ROC AUC值为0.85,且与放射科医生定性评估及短轴标准联合时有所改善。结论认为CNN能以中等准确度预测淋巴结SUVmax。
要点
- 3D CNN基于平扫CT和肿瘤组织学类型预测淋巴结SUVmax,与真实SUVmax相关(β估计值=0.83,p<0.0001)。
- 预测SUVmax判别FDG亲和性的ROC AUC值为0.85,与放射科医生定性评估及短轴标准联合时有所改善。
- 本研究为概念验证,CNN预测SUVmax的准确度为中等。
核心结论
- CNN能够以中等准确度预测癌症患者淋巴结的SUVmax,该预测基于平扫CT图像和肿瘤组织学亚型。
研究设计与样本
- 概念验证研究,训练集为136例患者的400枚淋巴结,测试集为49例患者的164枚淋巴结;输入为平扫CT图像和原发肿瘤组织学类型,输出为预测SUVmax;参考标准为PET/CT测得的真实SUVmax,FDG亲和性定义为SUVmax≥2.5。
关键影像表现/征象
- 训练集淋巴结中位SUVmax为6.8(IQR 2.7-11.6),中位短轴为1.1 cm(IQR 0.9-1.6 cm)。
- 测试集淋巴结中位SUVmax为3.5(IQR 1.9-8.6),中位短轴为1.0 cm(IQR 0.7-1.4 cm)。
诊断标准与关键数值
- FDG亲和性定义为SUVmax≥2.5。
- 预测SUVmax与真实SUVmax相关,β估计值=0.83,p<0.0001。
- 预测SUVmax与FDG亲和性相关(p<0.0001),ROC AUC值为0.85。
- 预测SUVmax与放射科医生定性评估及短轴标准联合时,判别FDG亲和性的性能有所改善。
临床应用与阅片要点
- 作者指出该研究为在平扫CT上利用深度学习诊断淋巴结受累提供了概念验证。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: The purpose of this study is to determine whether a convolutional neural network (CNN) can predict the maximum standardized uptake value (SUVmax) of lymph nodes in patients with cancer using the unenhanced CT images from a PET/CT examination, thus providing a proof of concept for potentially using deep learning to diagnose nodal involvement.
MATERIALS AND METHODS: Consecutive initial staging PET/CT scans obtained in 2017 for patients with pathologically proven malignancy were collected. Two blinded radiologists selected one to 10 lymph nodes from the unenhanced CT portion of each PET/CT examination. The SUVmax of the lymph nodes was recorded. Lymph nodes were cropped and used with the primary tumor histology type as input for a novel 3D CNN with predicted SUVmax as the output. The CNN was trained using one cohort and tested using a separate cohort. An SUVmax of 2.5 or greater was defined as FDG avid. Two blinded radiologists separately classified lymph nodes as FDG avid or not FDG avid on the basis of unenhanced CT images and separately using a short-axis measurement cutoff of 1 cm. Logistic regression analysis was performed.
RESULTS: A total of 400 lymph nodes (median SUVmax, 6.8 [interquartile range {IQR}, 2.7-11.6]; median short-axis, 1.1 cm [IQR, 0.9-1.6 cm]) in 136 patients were used for training. A total of 164 lymph nodes (median SUVmax, 3.5 [IQR, 1.9-8.6]; median short-axis, 1.0 cm [IQR, 0.7-1.4 cm]) in 49 patients were used for testing. The predicted SUVmax was associated with the real SUVmax (β estimate = 0.83, p < 0.0001). The predicted SUVmax was associated with FDG avidity (p < 0.0001), with an ROC AUC value of 0.85, and it improved when combined with radiologist qualitative assessment and short-axis criteria.
CONCLUSION: A CNN is able to predict with moderate accuracy the SUVmax of lymph nodes, as determined from the unenhanced CT images and tumor histology subtype for patients with cancer.
引用
- Shaish H, Mutasa S, Makkar J, et al. Prediction of Lymph Node Maximum Standardized Uptake Value in Patients With Cancer Using a 3D Convolutional Neural Network: A Proof-of-Concept Study. AJR Am J Roentgenol. 2018. PMID: 30540209. doi:10.2214/AJR.18.20094
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。